1. Home
  2. TKNO vs NKTR Comparison

TKNO vs NKTR Comparison

Compare TKNO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • NKTR
  • Stock Information
  • Founded
  • TKNO 1996
  • NKTR 1990
  • Country
  • TKNO United States
  • NKTR United States
  • Employees
  • TKNO N/A
  • NKTR N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TKNO Health Care
  • NKTR Health Care
  • Exchange
  • TKNO Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • TKNO 390.7M
  • NKTR 247.9M
  • IPO Year
  • TKNO 2021
  • NKTR 1994
  • Fundamental
  • Price
  • TKNO $7.73
  • NKTR $0.93
  • Analyst Decision
  • TKNO Buy
  • NKTR Buy
  • Analyst Count
  • TKNO 2
  • NKTR 3
  • Target Price
  • TKNO $5.00
  • NKTR $4.00
  • AVG Volume (30 Days)
  • TKNO 206.5K
  • NKTR 2.3M
  • Earning Date
  • TKNO 11-07-2024
  • NKTR 11-07-2024
  • Dividend Yield
  • TKNO N/A
  • NKTR N/A
  • EPS Growth
  • TKNO N/A
  • NKTR N/A
  • EPS
  • TKNO N/A
  • NKTR N/A
  • Revenue
  • TKNO $36,347,000.00
  • NKTR $93,137,000.00
  • Revenue This Year
  • TKNO $3.47
  • NKTR $12.85
  • Revenue Next Year
  • TKNO $12.07
  • NKTR N/A
  • P/E Ratio
  • TKNO N/A
  • NKTR N/A
  • Revenue Growth
  • TKNO N/A
  • NKTR 5.53
  • 52 Week Low
  • TKNO $1.16
  • NKTR $0.47
  • 52 Week High
  • TKNO $8.91
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 51.60
  • NKTR 33.04
  • Support Level
  • TKNO $7.00
  • NKTR $0.89
  • Resistance Level
  • TKNO $8.89
  • NKTR $1.04
  • Average True Range (ATR)
  • TKNO 0.74
  • NKTR 0.07
  • MACD
  • TKNO -0.09
  • NKTR -0.00
  • Stochastic Oscillator
  • TKNO 38.24
  • NKTR 14.81

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: